 Outlook Therapeutics NASDAQ:OTLK Inc has said its chief operations officer Terry Dagnon will discuss the companys wet age-related macular degeneration AMD drug Lytenava as part of a panel at the 2022 World Retina Conference later this month. The conference is taking place from May 12-15, 2022, in Fort Lauderdale, Florida. 